Proto Labs Inc
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $533.1M | $500.9M | $503.9M | $488.4M | $488.1M |
| Cost of revenue | $296.0M | $277.7M | $281.9M | $272.9M | $265.4M |
| Gross profit | $237.1M | $223.2M | $222.0M | $215.5M | $222.7M |
| Research and development | $42.8M | $41.3M | $40.1M | $38.2M | $44.2M |
| Operating expenses | $212.0M | $203.3M | $193.8M | $313.4M | $182.3M |
| Operating income | $25.1M | $19.9M | $28.2M | -$98.0M | $40.3M |
| Pretax income | $31.1M | $24.7M | $28.0M | -$97.9M | $40.2M |
| Income tax expense | $9.8M | $8.1M | $10.7M | $5.6M | $6.8M |
| Net income | $21.2M | $16.6M | $17.2M | -$103.5M | $33.4M |
| Balance Sheet | |||||
| Cash and equivalents | $110.8M | $89.1M | $83.8M | $56.6M | $65.9M |
| Current assets | $233.5M | $194.9M | $200.7M | $186.6M | $183.5M |
| Total assets | $763.4M | $743.5M | $772.4M | $802.2M | $928.6M |
| Current liabilities | $67.0M | $53.3M | $49.7M | $71.6M | $54.9M |
| Total liabilities | $89.5M | $73.4M | $77.1M | $104.5M | $100.1M |
| Stockholders' equity | $673.9M | $670.2M | $695.3M | $697.6M | $828.5M |
| Cash Flow Statement | |||||
| Cash from operations | $74.5M | $77.8M | $73.3M | $62.1M | $55.2M |
| Depreciation and amortization | $33.8M | $35.8M | $37.5M | $39.4M | $40.5M |
| Stock-based compensation | $15.7M | $17.0M | $16.0M | $17.5M | $19.1M |
| Capital expenditure | $14.8M | $9.2M | $28.1M | $21.7M | $34.2M |
| Free cash flow | $59.7M | $68.7M | $45.2M | $40.4M | $21.0M |
| Share repurchases | $43.0M | $60.3M | $44.0M | $29.7M | $23.3M |
| Impairments | $0 | $0 | $0 | $118.0M | $0 |
Shares outstanding 23.8M · Free float 98.7%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.